Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06040281
Other study ID # GE8-2496-IMV-2019-V2
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 18, 2023
Est. completion date December 31, 2025

Study information

Verified date September 2023
Source University of Erlangen-Nürnberg Medical School
Contact Helge Krusemark
Phone +4991318542966
Email helge.krusemark@uk-erlangen.de
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is a randomised controlled intervention trial for patients with chronic kidney disease who are on the waiting list for a kidney transplantation (n=200). The aim of this study is to test the effectiveness of intensive individual nutritional and exercise support combined with comprehensive rehabilitation before transplantation in comparison to a control group.


Description:

Patients are randomised to either the intervention or control group at the beginning of the study. Both groups are evaluated at the beginning after 6 months and after 12 months regarding their body composition, physical performance, blood values, quality of life and nutritional status. The control group only receives support via app during the study period (1 year), through which they receive detailed information about dialysis. In addition to access to the app, the intervention group receives individual recommendations for nutrition and exercise as well as a three-week inpatient rehabilitation.


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date December 31, 2025
Est. primary completion date December 31, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients must be on dialysis - Patients = 18 years of age - Patients who own a smartphone - Patients must be willing to undergo inpatient rehabilitation within the project period - signed informed consent and data protection regulation Exclusion Criteria: - Patients who are not psychologically or physically able to take part in exercise promotion measures and/or nutritional counselling as well as psychological offers - Patients who have already participated in a similar project

Study Design


Intervention

Behavioral:
intensive individual support in nutrition and exercise
Intensive care for nutrition and exercise adapted to the social context. Individualised exercise and nutrition recommendations. three weeks of inpatient rehabilitation with an individual plan of treatment, which includes medical care, sports therapy, physiotherapy, ergotherapy, nutritional education and psychological care App access for comprehensive information about dialysis (nutrition, travel, medication, etc.)
Usual Care
Usual care App access for comprehensive information about dialysis (nutrition, travel, medication, etc.)

Locations

Country Name City State
Germany Universitätsklinikum Erlangen Erlangen Bavaria

Sponsors (4)

Lead Sponsor Collaborator
University of Erlangen-Nürnberg Medical School Carealytix Digital Health GmbH, m&i Fachklinik Bad Heilbrunn, m&i-Fachklinik Herzogenaurach

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary muscle mass measured in kg by bio-impedance analysis 6 and 12 month
Primary body fat mass measured in kg by bio-impedance analysis 6 and 12 month
Secondary Six-Minutes-Walk test (6MWT) measured in distance (meter) 6 and 12 month
Secondary Sit-to-stand test (STS60) measured in number of repetitions in 60 seconds 6 and 12 month
Secondary Timed-up-and-go test (TUG) measured in time (seconds) 6 and 12 month
Secondary Quality of life by Short Form Health Survey (SF-12) measured in change of scale by questionnaire 6 and 12 month
Secondary Fried Frailty Scale measured in change of score (score of 0 = not frail; score of 1-2 = pre-frail; score of 3-5 = frail) 6 and 12 month
Secondary One-Legged Stance Test measured in time (seconds) 6 and 12 month
Secondary Stair Climb Test measured in time (seconds) 6 and 12 month
See also
  Status Clinical Trial Phase
Completed NCT05700851 - Immuno-nutrition Supplementation in Haemodialysis N/A
Recruiting NCT02616627 - Association Between DXA Results and the Complications, Clinical Courses and Outcomes in Chronic Dialysis Patients
Completed NCT01464190 - A Phase 3 Extension Study to Investigate the Long-term Safety, Tolerability and Efficacy of PA21, a Phosphate Binder in Dialysis Patients Phase 3
Active, not recruiting NCT03535922 - Evaluation of Routinely Measured Patient-reported Outcomes in Hemodialysis Care N/A
Completed NCT04622709 - Pilot Study of Loop Diuretics Among Individuals Receiving Hemodialysis Phase 2
Completed NCT04585607 - Potential Benefits of Expanded Hemodialysis in Prevention of Sarcopenia Phase 4
Completed NCT03182699 - Effect of Etelcalcetide on Cardiac Hypertrophy in Hemodialysis Patients Phase 4
Completed NCT03942744 - The Effect of High-flux Hemodialysis and On-line Hemodiafiltration on Endothelial Function. N/A
Completed NCT04549597 - Study to Evaluate the Use of Tenapanor as Core Therapy in the Treatment of Hyperphosphatemia Phase 4
Recruiting NCT04659525 - Evolocumab Plus Ezetimibe in Haemodialized Statin-intolerant Patients With Hypercholesterolemia Phase 4
Completed NCT04125537 - Pathways Project: Kidney Supportive Care
Recruiting NCT03347773 - Oral Nutritional Supplement Intervention Among Hemodialysis Patients With Sarcopenic Obesity N/A
Recruiting NCT04397653 - Evolocumab Plus Ezetimibe in High Risk Haemodialized Statin Intolerant Patients Phase 4
Active, not recruiting NCT03938285 - Effect of Hemodiafiltration Plus MCOs on Uremic Toxins Removal N/A
Completed NCT03525223 - Modulation of Tissue Sodium in Hemodialysis Patients N/A
Completed NCT01324128 - A Phase 3 Study to Investigate the Safety and Efficacy of PA21, a Phosphate Binder, in Dialysis Patients Phase 3
Not yet recruiting NCT04600193 - a Randomized Controlled Trial of the Intake of Organic and Inorganic Phosphate in Peritoneal Dialysis Patients N/A
Not yet recruiting NCT06225544 - Lumasiran in Hyperoxalaemic Patients on Haemodialysis Phase 2
Recruiting NCT05209880 - Advance Care Planning in the Emergency Department N/A
Enrolling by invitation NCT05086185 - Effect of Viscous Fiber on Postprandial Kalemic Response in Hemodialysis Patients